Daily Archives: April 29, 2014

Mind and Heart

The Washington Post recently carried an article regarding an investigative compound being studied for the treatment of Duchenne muscular dystrophy which affects young boys – a condition for which there is no current treatment.  The course of the condition means … Continue reading

Posted in FDA Policy | Comments Off on Mind and Heart